Gene inhibition provides potential way to overcome cancer cells' resistance to chemotherapy drug cisplatin
A new study from Cedars-Sinai Cancer reveals a potential way to overcome tumor resistance to a common chemotherapy drug ...
kpvi2d
Last Year's Platinum-Based Drugs Shortage Didn't Raise Cancer Deaths, Study Found
TUESDAY, Dec. 24, 2024 (HealthDay News) -- When supplies of certain generic, platinum-based cancer chemotherapies dwindled in ...
NHS to get drug which helps prevent hearing loss in children having chemotherapy
A “groundbreaking” drug which helps to prevent hearing loss among children undergoing cancer treatment has been given the ...
Novel platinum complex shows strong antiproliferative effects with low toxicity in preclinical prostrate cancer models
Prostate cancer remains a global health challenge, ranking as the second most commonly diagnosed cancer among men. Although ...
Science Daily9d
Treating prostate cancer with novel platinum complex via targeting androgen receptor signaling
Prostate cancer, especially in advanced stages such as castration-resistant prostate cancer, is challenging to treat. Traditional therapies targeting androgen receptor (AR) signaling have limited ...
The American Journal of Managed Care7d
The High Cost of Shortages of Low-Cost Chemotherapy
The 2023 chemotherapy shortage led to a 60% drop in cisplatin use for head and neck cancer, with costly substitutes ...
U.S. News & World Report1mon
There's a Best Option for Patients With Head-and-Neck Cancer Who Can't Take Cisplatin
There's a Best Option for Patients With Head-and-Neck Cancer Who Can't Take Cisplatin By Ernie Mundell HealthDay Reporter TUESDAY, Nov. 26, 2024 (HealthDay News) -- Cisplatin is the go-to ...
Fennec' Pedmarqsi Gets Support From NICE For Cisplatin-Induced Hearing Loss Prevention
(RTTNews) - Fennec Pharmaceuticals Inc. (FENC), Friday announced that the National Institute for Health and Care Excellence or NICE has recommended Pedmarqsi, intended for the prevention of ...
Science Daily12d
Generic platinum chemotherapy shortages did not increase deaths
An analysis of national data found that short-term mortality was not impacted for patients with advanced cancers during the shortage of the generic platinum chemotherapy drugs cisplatin and ...
Research finds no change in mortality despite platinum chemotherapy shortage
During a shortage of the generic platinum chemotherapy drugs cisplatin and carboplatin that began in early 2023, there was no difference in mortality rates among patients with advanced cancer compared ...
Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales
PEDMARQSI® (anhydrous sodium thiosulfate) is the first and only treatment available within NHS England and Wales for the prevention of ...